None listed
Conditions
Interventions
Intervention1: Zandu Lalima: Observation: Baseline, week 5, week 8, week 10.
Direction: take 2 teaspoonfuls of Zandu Lalima, twice daily after meals for 8 weeks.
Assessments: Dermatologist, Instrumen
Sponsors
EMAMI LIMITED
Eligibility
Inclusion criteria
Inclusion criteria: 1. Volunteer in generally good health. 2. Volunteer between the ages of 18 to 25 years. 3. Volunteer suffering from mild to moderate symptoms of acne vulgaris (pimples). 4. Volunteer having regular menstrual cycles of approximately 25 to 35 days. 5. Volunteer willing to do blood test as per study requirement. 6. Volunteer willing for still photography. 7. Volunteer has not participated in a similar clinical investigation in the past four weeks. 8. Volunteer without known allergy/ sensitivity to cosmetic products or fragrance and without any skin allergies / infections. 9. Volunteer not under any dermatologic treatment / prescribed medications. 10. Volunteer willing to abstain from using any cosmetic product on face, besides the provided product during the entire study course. 11. Volunteer willing to visit the site at specified frequencies for periodic evaluations. 12. Volunteer willing to comply with study specific requirements. 13. Volunteer willing to give a written informed consent and come for regular observation.
Exclusion criteria
Exclusion criteria: 1. A known history or present condition of allergic response to any cosmetic products. 2. Skin disease except acne vulgaris (pimples) (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings. 3. Medications (e.g. steroids or antihistamines), which would compromise the study. 4. Currently or has been undergoing dermatologist facial treatments or procedures within the last 1 month. 5. Subject viewed by the investigator as not being able to complete the study or participating in another study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a) The purpose of this study is to evaluate the efficacy of Zandu Lalima in acne vulgaris (pimples) & Skin Fairness. b) To evaluate the efficacy of test drug Zandu Lalima in comparison to standard therapeutic Topical Cream available at present in term of Mild to Moderate acne vulgaris (pimples) &Skin Fairness. c) Safety of the test drug in above protocol by evaluating through questionnaire / clinical measurement & other biochemical parameters.Timepoint: This will be a 10 weeks study. All the subjects will be assessed on Baseline, week 5, week 8 and week 10. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the compliance of the therapy in respect of available drugs and also the quality of life.Timepoint: This will be a 10 weeks study. All the subjects will be assessed on Baseline, week 5, week 8 and week 10. | — |
Countries
India
Contacts
Public ContactMs Yamini Patil
KETs Scientific Research Centre
Outcome results
None listed